Antacids Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report, 2025
“The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast.”
The global Antacids Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to the increasing geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill effects of anti-inflammatory, non-steroidal drugs. It’s a known fact that amongst the elderly populace, there is a recurrence of acidic complications. This comes across as a challenge for gastroenterologists as well as the primary care provider. Plus, these patients do suffer from disorders like erosive esophagitis, esophageal cancer, and Barrett's esophagus. The treatment herein needs an amalgamation of therapies. This is where antacids come into the picture. The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy’s Laboratories Ltd. Request free sample to get a complete analysis of the market players @ https://www.millioninsights.com/industry-reports/antacids-market/request-sample Besides, growth in e-Commerce is expected to drive demand for antacids via online retailing channels in the subsequent years. In other words, growing popularity on the part of e-Commerce coupled with an increase in online medicine providers is expected to bolster the market. At the same time, restraints do exist in the form of intake by young children. “Gut” journal states that young children displayed obesity
symptoms on intake of antacids. As far as infants are concerned, antacids are a strict “no-no”. Even during pregnancy antacids should be avoided as chances of pre-mature birth can’t be ruled out. Antacid Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)
Tablet
Liquid
Others
Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Industry Outlook:
Value chain analysis
Vendor landscape
Raw material outlook
Technology overview
Regulatory framework
Market driver analysis
Market restraint analysis
Key market opportunities – Prioritized
Industry analysis – Porter’s
Competitive landscape
PESTEL analysis
The antacids market is segmented based on drug class, type of formulation, distribution channel, and geography. By drug class, the segmentation spans proton pump inhibitors, and H2 antagonists (interventional/surgical simulators), and acid neutralizers. By geography, the antacid market is segmented into North America, LATAM, Asia Pacific, Europe, and MEA. Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/
Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com
Global Headquarters
Asia Pacific
Million Insights
Million Insights
410 E Santa Clara Street,
Office No. 302, 3rd Floor, Manikchand Galleria,
Unit #1008 San Jose, CA, 95113, United States
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 1-408-610-2300 Email: sales@millioninsights.com
Phone: +91-8956380892 Email: sales@millioninsights.com